| dc.contributor.author | Wilkins, A | |
| dc.contributor.author | Melcher, A | |
| dc.contributor.author | Somaiah, N | |
| dc.date.accessioned | 2018-07-16T13:29:16Z | |
| dc.date.accessioned | 2018-08-14T09:49:09Z | |
| dc.date.issued | 2018-10-01 | |
| dc.identifier.citation | Clinical oncology (Royal College of Radiologists (Great Britain)), 2018, 30 (10), pp. 605 - 608 | |
| dc.identifier.issn | 0936-6555 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/2331 | |
| dc.identifier.eissn | 1433-2981 | |
| dc.identifier.doi | 10.1016/j.clon.2018.07.001 | |
| dc.format | Print-Electronic | |
| dc.format.extent | 605 - 608 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER SCIENCE LONDON | |
| dc.relation.replaces | https://repository.icr.ac.uk/handle/internal/2075 | |
| dc.relation.replaces | internal/2075 | |
| dc.relation.replaces | internal/2324 | |
| dc.relation.replaces | https://repository.icr.ac.uk/handle/internal/2324 | |
| dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| dc.title | Science in Focus: Biological Optimisation of Radiotherapy Fraction Size in an Era of Immune Oncology. | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2018-06-28 | |
| rioxxterms.versionofrecord | 10.1016/j.clon.2018.07.001 | |
| rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| rioxxterms.licenseref.startdate | 2018-10 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | Clinical oncology (Royal College of Radiologists (Great Britain)) | |
| pubs.issue | 10 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Breast Radiobiology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Immunotherapy | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Immunotherapy/Translational Immunotherapy (TL) | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Breast Radiobiology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Immunotherapy | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Immunotherapy/Translational Immunotherapy (TL) | |
| pubs.publication-status | Published | |
| pubs.volume | 30 | |
| pubs.embargo.terms | Not known | |
| icr.researchteam | Targeted Therapy | |
| icr.researchteam | Translational Breast Radiobiology | |
| icr.researchteam | Translational Immunotherapy | |
| dc.contributor.icrauthor | Corbett, Anna | |
| dc.contributor.icrauthor | Melcher, Alan | |
| dc.contributor.icrauthor | Somaiah, Navita | |
